Jul 2026
A novel double-stranded RNA adjuvant markedly amplifies the immunogenicity of nucleoside-modified mRNA-LNP vaccines 2256634
The dsRNA-LNP acts as a potent adjuvant for nucleoside-modified mRNA vaccination, inducing a strong immune activation, representing a potent platform for eliciting balanced, durable antiviral immunity.
F. Coirada, Nelson Cortes Oliveira, Emily F. Daley et al.
· Journal of Immunology · 0 citations